Sage Journals: Discover world-class research

Abstract

The aim of this study was to assess the skeletal metabolism in a murine model of systemic lupus erythematosus (SLE). MRL/n and MRL/l mice (respectively representing a benign and a malignant form of the disease) were observed from 1.5 to 6.5 months of life. The monthly follow-up included: biochemical and histomorphometrical studies of the femoral bone, serum biochemistry, immunoglobulins and osteocalcin, and histological evaluation of the kidney tissue. The results showed a higher femoral weight (/ 11.5%), calcium (/ 4.4%) and protein bone content (/ 11.4%) and a significantly higher (/ 77%) phosphorus bone content in the MRL =n group; significantly lower (748.9%) bone alkaline phosphatase enzymatic activity, lower bone alkaline/acid phosphatase enzymatic activities ratio (740.8%) and lower (738.4%) serum osteocalcin values in the MRL/l group (which might suggest reduced bone formation in these animals); markedly smaller trabecular bone volume (BV/TV) in the femoral head (736.2%) and femoral neck (739.8%), and smaller cortical and femoral areas in the mid-femoral shaft (738.8% and 738.1% respectively) in the MRL/l group; higher serum immunoglobulins, increased serum blood urea nitrogen (BUN) and creatinine and a higher index of activity in the kidney histology in the MRL/l group, indicating increased activity of the disease in this substrain. The MRL mice, through their two substrains, may serve as a valuable laboratory animal model for study of the skeletal changes in SLE and of the influence of the disease activity on the skeletal metabolism.

Keywords

SLE mice bone osteoporosis

Get full access to this article

View all access options for this article.

References

Gladman DD , Urowitz MB . Systemic lupus erythematosus. I. Clinical features. In: Klippel JH , Dieppe PA (eds). Rheumatology, Vol 7. Mosby: St Louis, MO , 1998, pp 11–18.

Kalla AA , Ftaar AB , Jessop SJ , Bewerunge L . Loss of trabecular bone mineral density in systemic lupus erythematosus . Arthrit Rheum 1993; 36: 1726-1734 .

Formiga F , Moga I , Nolla JM , Pac M , Mitjavilla F , Roig-Escofet D . Loss of bone mineral density in premenopausal women with systemic lupus erythematosus . Ann Rheum Dis 1995; 54: 274–276 .

Petri M . Musculoskeletal complications of systemic lupus erythematosus in the Hopkins Lupus cohort: an update . Arthrit Care Res 1995; 8: 137–145 .

Pons F , Perris P , Guañabens N et al. The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in premenopausal women . Br J Rheumatol 1995; 34: 742–746 .

Dhillon VB , Davies MC , Hall ML et al. Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy and ray absorptiometry . Ann Rheum Dis 1990; 49: 624–626 .

Askari A , Vignos PJ Jr , Moskowitz RW . Steroid myophathy in connective tissue disease . Am J Med 1976; 61: 485–492 .

Babini SM , Arturi A , Marcos JC , Babini JC , Iniquet AM , Morteo OG . Laxity and rupture of the patellar tendon in systemic lupus erythematosus: association with secondary hyperparathyroidism . J Rheumatol 1988; 15: 1162–1165 .

Seitz M , Hunstein W . Enhanced prostanoid release from monocytes of patients with rheumatoid arthritis and active systemic lupus erythematosus . Ann Rheum Dis 1985; 44: 438–445 .

10.

Tanaka Y , Watanabe K , Suzuki M et al. Spontaneous production of bone resorbing lymphokines by B cells in patients with systemic lupus erythematosus . J Clin Immunol 1989; 9: 415–420 .

11.

Matsushita M , Tsuboyama T , Kasai R et al. Age-related changes in bone mass in the senescence-accelerated mouse SAM-R=3 and SAMP=6 as new murine models for senile osteoporosis . Am J Pathol 1986; 125: 276–283 .

12.

Bar-Shira-Maymon B , Coleman R , Cohen A , Steinhagen-Thiessen E , Silbermann M . Age-related bone loss in lumbar vertebrae of CW-1 female mice: a histomorphometric study . Calcif Tissue Int 1989; 44: 36–45 .

13.

Weiss A , Arbell I , Steinhagen-Thiessen E , Silbermann M . Structural changes in aging bone: osteopenia in the proximal femurs of female mice . Bone 1991; 12: 165–172 .

14.

Bain SD , Bailey MC , Edwards MW . The anabolic effect of estrogen on the endosteal bone formation in the mouse is attenuated by ovariohysterectomy: a role for the uterus in the skeletal response to estrogen . Calcif Tissue Int 1992; 51: 223–228 .

15.

Takahashi K , Tsuboyuma T , Matsushita M et al. Effective intervention of low peak bone mass and bone modeling in the spontaneous murine model of senile osteoporosis, SAM-p=6 by Ca supplement and hormone treatment . Bone 1994; 15: 209–215 .

16.

Theofilopoulos AN , Dixon FJ . Etiopathogenesis of murine SLE . Immunol Rev 1981; 55: 179–216 .

17.

Theofilopoulos AH , Dixon FJ . Murine models of systemic lupus erythematosus . Adv Immunol 1985; 37: 269–380 .

18.

Moscovitch M , Rosenmann E , Neeman Z , Slavin I . Successful treatment of autoimmune manifestations in MRL/l and MRL/n mice using total lymphoid irradiation (TLI) . Exp Mol Pathol 1983; 38: 33–47 .

19.

Bernstein KA , Balshoun D , Lefkowith JB . Serum glomerular binding activity is highly correlated with renal disease in MRL/lpr mice . Clin Exp Immunol 1993; 93: 418–423 .

20.

Warner LM , Adams LM , Sehgal SN . Rapamycin prolongs survival and arrests pathophysiologic changes in murine systemic lupus erythematosus . Arthrit Rheum 1994; 37: 289–297 .

21.

Karussis DM , Vourka-Karussis U , Lehman D , Abramsky O , Ben-Nun A , Slavin S . Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT) . Clin Exp Immunol 1995; 100: 111–117 .

22.

Lowry OH , Rosenbrough HJ , Farr AL , Randel RJ . Protein measurement with pholin phenol reagent . J Biol Chem 1951; 193: 263–275 .

23.

Silbermann M , Redali HA , Hana AR , Leapman K , Von der Mark K , Frazen A . Chondroid bones arise from mesenchymal stem cells in organ culture of mandibular condyles . J Cranofacial Genet Devl Biol 1987; 7: 59–79 .

24.

Ballow JE , Austin HA III . Renal disease in systemic lupus erythematosus . Rheum Dis Clin N Am 1988; 14: 117–133 .

25.

Formiga F , Nolla JM , Mitjavilla F , Bonnin R , Navaro MA , Moga I . Bone mineral density and hormonal status in men with systemic lupus erythematosus . Lupus 1996; 5: 623–626 .

26.

Formiga F , Nolla JM , Moga I , Roig-Escofet D . Sequential study of bone mineral density in patients with systemic lupus erythematosus . Ann Rheum Dis 1996; 55: 857–857 .

27.

Reisenfeld R . Age changes of bone life and mass in two strains of senescent rats . Acta Anat 1981; 109: 64–69 .

28.

Simon MR . The rat as an animal model for the study of senile idiopathic osteoporosis . Acta Anat 1984; 119: 248–250 .

29.

Schapira D , Lotan-Miller R , Barzilai D , Silbermann M . The rat as a model for studies of the aging skeleton . Cells Mater 1991; 1(Suppl): 181–189 .

30.

Silbermann M , Weiss A , Reznick AZ , Eilam Y , Szydel N , Gershon D . Age-related trend for osteopenia in femurs of female C57B1=6 mice . Comp Gerontol 1987; 1: 45–51 .

31.

Takeda T , Hosokawa M , Higuchi K . Senescence-accelerated mouse(SAM). A novel murine model of accelerated senescence . JAGS 1991; 39: 911–919 .

32.

Cohen MB , Pollard KM , Schrieber L . Relationship of age and sex to autoantibody expression in MRL+/+ and MRL-lpr/lpr mice: demonstration of an association between the expression of antibodies to histones, denaturated DNA and Sm in MRL +/+ mice . Clin Exp Immunol 1988; 72: 50–54 .

33.

Seggev JS , Sunderrajan EV , Palomo T et al. Pulmonary perivascular and interstitial inflammation in MRL/MpJ-lpr/lpr mice . Clin Immunol Immuno-pathol 1991; 60: 289–298 .

34.

Hess DC , Taormina M , Thomson J et al. Cognitive and neurologic deficits in MRL/lpr mouse: a clinicopathological study . J Rheumatol 1993; 20: 610–617 .

35.

Schapira D , Linn S , Sarid M , Mokadi S , Kabala A , Silbermann M . Calcium and vitamin D enriched diets increase and preserve vertebral mineral content in aging laboratory rats . Bone 1995; 16: 575–582 .

36.

Siffert RS . The role of alkaline phosphatase in osteogenesis . J Exp Med 1951; 93: 415–422 .

37.

Lau K , Onishi T , Wergetal JE , Singer FR , Baylin KD . Characterization and assay of tartrate-resistant acid phosphatase activity in serum: potential uses to assess bone resorption . Clin Chem 1987; 33: 458-462 .

38.

Stepan YY , Silinkova-Malkova E , Havranek T et al. Relationship of plasma tartrate-resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism . Clin Chim Acta 1983; 133: 189–200 .

39.

Warady BD , Lindsley CB , Robinson FG , Lukert BP . Effects of nutritional supplementation on bone mineral status of children with rheumatic diseases receiving corticosteroid therapy . J Rheumatol 1994; 21: 530–535 .

40.

Trapani S , Civinini R , Ermini M , Paci E , Falcini F . Osteoporosis in juvenile systemic lupus erythematosus: a longitudinal study on the effect of steroids on bone mineral density . Rheumatol Int 1998; 18: 45–49 .

41.

Arkachaisri T , Llehman TJ . Systemic lupus erythematosus and related disorders of childhood . Curr Opin Rheumatol 1999; 11: 384–392 .

Osteoporosis in murine systemic lupus erythematosus - a laboratory model

Abstract

Keywords

Get full access to this article

References